Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

HHS partners with PEPFAR to invest $130M for African medical education

The U.S. Department of Health and Human Services is partnering with the U.S. President's Emergency Plan for AIDS Relief with a plan to invest $130 million over five years to transform African medical education and dramatically increase the number of health care workers.

7 Oct 2010

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, and Mission Pharmacal Company, a privately-held pharmaceutical company focused on the women's health market announced today their exclusive co-promotion agreement for CAMBIA (diclofenac potassium for oral solution) to obstetrician's, gynecologists and other women's health medical professionals.

6 Oct 2010

MEPs organizes joint meeting to improve policies for tackling chronic diseases

In an unprecedented effort to bring prevention of chronic diseases to the top of the EU agenda, the MEP Heart Group , the MEP Group for Kidney Health , the EU Diabetes Working Group and MEPs Against Cancer organise a joint meeting today in the European Parliament, together with representatives of health professionals and health activists at European level.

6 Oct 2010

Focused Ultrasound Surgery Foundation hosts conference to discuss advancements in therapeutic medicine

The Focused Ultrasound Surgery Foundation is hosting the 2nd International Symposium on MR-guided Focused Ultrasound in Chantilly, Virginia from October 17-20. Leading researchers and clinicians from around the world will gather at the three-day scientific conference to present and discuss the latest advancements in one of the most revolutionary and promising areas of therapeutic medicine.

6 Oct 2010

Way of VAD implantation can impact stroke occurrence

A surgical team from the University of Central Florida College of Medicine and Arnold Palmer Hospital for Children, Orlando, has presented findings from the first study to demonstrate that the way a ventricular assist device (VAD) is implanted can have an impact on whether or not a patient may have a stroke while the device is in use.

6 Oct 2010

New hope for patients with brain injury

New neuroscience research by life scientists from UCLA and Australia may potentially help people who have lost their ability to remember due to brain injury or disease.

6 Oct 2010

Healthcare organizations urge Congress to raise awareness on sudden cardiac arrest

In a powerful demonstration of collective standing in the health care community, more than 40 organizations gathered on Capitol Hill to issue a call to action in reducing sudden cardiac arrest (SCA) deaths.

6 Oct 2010

Amgen to present oncology portfolio results at ESMO Congress

Amgen today announced that results from several important studies from the Company's ncology portfolio will be presented at the 35th European Society for Medical Oncology (ESMO) Congress, Oct. 8-12, 2010, in Milan, Italy.

6 Oct 2010

microRNA miR-33 may help control blood cholesterol level

Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.

6 Oct 2010

Saneron receives grant to develop safety guidelines for transplanting HUBC cells in Alzheimer's disease

The National Institutes of Health has awarded a three-year, $2.6-million grant to the University of South Florida and Tampa-based biotechnology company Saneron-CCEL Therapeutics, Inc., to establish dosing and safety guidelines for transplanting human umbilical cord blood cells (HUBC) into animal models of Alzheimer's disease.

6 Oct 2010

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.

6 Oct 2010

Lixte, NCI collaborate for clinical evaluation of LB-100 compound

Lixte Biotechnology Holdings announced today that the National Cancer Institute Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), signed a NExT Material Transfer Agreement formalizing a collaboration with Lixte Biotechnology Holdings, Inc. for clinical evaluation of LB-100, one of Lixte's lead anti-cancer compounds.

6 Oct 2010

American Heart Association addresses the use of arteriotomy closure devices

Re-opening a blocked heart artery isn't the only procedure that concerns doctors when they thread instruments through an opening in a thigh artery and into a heart artery. Closing up the thigh artery is also a concern.

5 Oct 2010

Calif. Governor signs law for oversight of CT scans; Ariz. man's transplant on hold because of Medicaid cuts; Texas pharmacies sue CVS Caremark

California Gov. Arnold Schwarzenegger has signed tough new legislation tightening oversight of diagnostic CT scans, largely in response to the overdosing of hundreds of patients who underwent brain scans for stroke in 2008 and 2009.

5 Oct 2010

Researchers identify new type of cell that protects from immune system attack

Researchers at the Dana-Farber Cancer Institute in Boston have identified a new type of cell in mice that dampens the immune system and protects the animal's own cells from immune system attack.

5 Oct 2010

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

Georgia Tech and Emory University have received a five-year $14.6 million contract from the National Institutes of Health (NIH) to continue the development of nanotechnology and biomolecular engineering tools and methodologies for detecting and treating atherosclerosis.

5 Oct 2010

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.

4 Oct 2010

Welch Allyn launches Connex ProBP handheld automated digital blood pressure device

Welch Allyn, a leading global provider of frontline medical products and solutions, today introduced the Connex® ProBP™ 3400, an automated digital blood pressure device designed to fit in the palm of the hand. Borrowing Welch Allyn SureBP™ technology from the company's multiparameter vital signs devices, the Connex ProBP delivers fast, accurate blood pressure readings with the durability of Welch Allyn's popular hospital-grade vital signs devices.

4 Oct 2010

Advances in treatment and management of neurological disorders

The latest advances in treating neurologic disorders such as stroke, headache, Parkinson's disease, epilepsy and sleep disorders are detailed in a special issue of the journal Neurologic Clinics.

4 Oct 2010

New edition of Sturge-Weber Syndrome textbook published

Eleven years after the first edition, a new edition of the Sturge-Weber Syndrome textbook has been published by the Sturge-Weber Foundation in New Jersey. Co-author E. Steve Roach, MD, is chief of Neurology and vice-chair of Pediatrics at Nationwide Children's Hospital.

4 Oct 2010

Stroke News and Research

Further Reading

HHS partners with PEPFAR to invest $130M for African medical education

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

MEPs organizes joint meeting to improve policies for tackling chronic diseases

Focused Ultrasound Surgery Foundation hosts conference to discuss advancements in therapeutic medicine

Way of VAD implantation can impact stroke occurrence

New hope for patients with brain injury

Healthcare organizations urge Congress to raise awareness on sudden cardiac arrest

Amgen to present oncology portfolio results at ESMO Congress

microRNA miR-33 may help control blood cholesterol level

Saneron receives grant to develop safety guidelines for transplanting HUBC cells in Alzheimer's disease

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Lixte, NCI collaborate for clinical evaluation of LB-100 compound

American Heart Association addresses the use of arteriotomy closure devices

Calif. Governor signs law for oversight of CT scans; Ariz. man's transplant on hold because of Medicaid cuts; Texas pharmacies sue CVS Caremark

Researchers identify new type of cell that protects from immune system attack

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Welch Allyn launches Connex ProBP handheld automated digital blood pressure device

Advances in treatment and management of neurological disorders

New edition of Sturge-Weber Syndrome textbook published

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News